MedElevator Войти в исследования
← Поиск публикаций

DOI 10.20524/aog.2022.0709

Медицинская библиотека · Annals of gastroenterology · 2022

Prevalence of abnormal liver biochemistry and its impact on COVID-19 patients' outcomes: a single-center Greek study.

Cholongitas Evangelos, Bali Triada, Georgakopoulou Vasiliki E, Giannakodimos Alexios, Gyftopoulos Argyrios, Georgilaki Vasiliki, Gerogiannis Dimitrios, Basoulis Dimitrios, Eliadi Irene, Karamanakos Georgios, Mimidis Konstantinos, Sipsas Nikolaos V, Samarkos Michael

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Abnormalities in aminotransferases are frequently observed in hospitalized COVID-19 patients, but their clinical impact is poorly characterized.

METHODS

A total of 1046 patients hospitalized to the non-intensive care unit ward with documented COVID-19 were included retrospectively. Demographic, clinical and laboratory characteristics on admission and during hospital stay, including the presence of liver injury (LI), defined as aspartate aminotransferase (AST) >200 IU/L, were recorded.

RESULTS

On admission, 363 (34.7%) and 269 (25.7%) patients had abnormal AST and ALT values (i.e., >40 IU/L), respectively, while during hospitalization 53 (5%) patients fulfilled the criteria for LI. In multivariate logistic regression analysis, AST (odds ratio [OR] 1.023, 95% confidence interval [CI] 1.016-1.029; P<0.001), and ferritin (OR 1.01, 95%CI 1.001-1.02; P<0.001) were the baseline factors independently associated with the development of LI during hospital stay. One hundred twenty-three (11.7%) patients died during hospitalization. The independent variables associated with mortality were: age (hazard ratio [HR] 1.043, 95%CI 1.029-1.056; P<0.001), ferritin (HR 1.1, 95%CI 1.05-1.2; P<0.001), platelets (HR 0.996, 95%CI 0.994-0.999; P=0.003), and administration of remdesivir (HR 0.50, 95%CI 0.30-0.85; P=0.009). The patients with abnormal baseline AST (i.e., >40 IU/L), compared to those with normal AST values, had worse outcomes (log rank test: 8.8, P=0.003).

CONCLUSIONS

Elevated aminotransferases are commonly seen in COVID-19 patients. They possibly reflect disease severity and may be associated with in-hospital mortality.

Для цитирования: Cholongitas Evangelos, Bali Triada, Georgakopoulou Vasiliki E, Giannakodimos Alexios, Gyftopoulos Argyrios, Georgilaki Vasiliki, Gerogiannis Dimitrios, Basoulis Dimitrios, Eliadi Irene, Karamanakos Georgios, Mimidis Konstantinos, Sipsas Nikolaos V, Samarkos Michael. Prevalence of abnormal liver biochemistry and its impact on COVID-19 patients' outcomes: a single-center Greek study.. Annals of gastroenterology. 2022. DOI: 10.20524/aog.2022.0709.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.